Guang Zhou GRG Metrology & Test Co., Ltd. (002967.SZ) Bundle
Curious how Guang Zhou GRG Metrology & Test Co., Ltd. (002967.SZ) really stacks up for investors? In the nine months ending September 30, 2025 the group delivered revenue of CNY 2.416 billion (up 12% YoY) and net income of CNY 238.82 million with a nine-month EPS of CNY 0.43, while TTM revenue as of March 2025 reached CNY 3.237 billion; beneath those top-line gains sit a gross profit margin of 38.68% and a net margin of 11.61% alongside ROE at 11.29%, but investors should weigh valuation and leverage - market cap stands at CNY 11.52 billion with a trailing P/E of 28.86 and P/S of 3.33, EV/EBITDA of 14.14 and debt-to-EBITDA of 1.92 - and remember the company earns ~92% of revenue domestically, has over 70% exposure to manufacturing and transportation, about 40% of equipment older than five years, and operational margins (~10%) trailing local peers even as management targets growth via R&D (≈CNY 300 million in 2022, ~15% of revenue), new calibration services (projected +CNY 100 million), and global expansion; read on for a chapter-by-chapter breakdown of revenue, profitability, liquidity, valuation, risks and growth levers that matter for your investment decisions
Guang Zhou GRG Metrology & Test Co., Ltd. (002967.SZ) - Revenue Analysis
Guang Zhou GRG Metrology & Test Co., Ltd. reported robust top-line performance in recent periods, driven primarily by domestic demand and sustained product/service uptake across its metrology and testing segments. Key headline figures show accelerating sales and healthy revenue per employee metrics, supporting effective scale in a largely China-focused revenue mix.- Nine months ending September 30, 2025 revenue: CNY 2.416 billion (+12% YoY vs. 9M 2024).
- TTM revenue as of March 2025: CNY 3.237 billion, reflecting continued sequential growth.
- Reported revenue growth rate (YoY): 12.24%.
- Revenue per employee: ~CNY 571,653 - an indicator of operational efficiency.
- Market capitalization: CNY 11.52 billion; P/S ratio: 3.33.
- Geographic revenue split: ~92% domestic (China), ~8% international.
| Metric | Value | Period / Note |
|---|---|---|
| Nine-month Revenue | CNY 2,416,000,000 | Ended Sep 30, 2025 (+12% YoY) |
| Trailing Twelve Months (TTM) Revenue | CNY 3,237,000,000 | As of Mar 31, 2025 |
| Revenue Growth Rate (YoY) | 12.24% | Annualized growth indicator |
| Revenue per Employee | CNY 571,653 | Productivity proxy |
| Market Capitalization | CNY 11,520,000,000 | Market value |
| Price-to-Sales (P/S) | 3.33 | Valuation multiple vs. sales |
| Domestic Revenue Share | ~92% | Geographic concentration |
- Primary revenue drivers: domestic instrument sales, calibration/testing services, and recurring service contracts.
- Risks to growth: concentration in China (92% of sales), potential cyclical demand in industrial end-markets, and foreign expansion pace.
- Efficiency signals: revenue/employee ~CNY 571k suggests scalable operations relative to peers in precision instrumentation.
Guang Zhou GRG Metrology & Test Co., Ltd. (002967.SZ) - Profitability Metrics
Key profitability indicators for the nine months ending September 30, 2025, highlight an improving earnings profile and solid margins for Guang Zhou GRG Metrology & Test Co., Ltd. (002967.SZ).
- Net income (9M 2025): CNY 238.82 million (up from CNY 188.77 million in 9M 2024)
- Basic EPS (9M 2025): CNY 0.43 (9M 2024: CNY 0.33)
- Return on equity (ROE): 11.29%
- Net profit margin: 11.61%
- Gross profit margin (9M 2025): 38.68%
- Trailing P/E: 28.86
| Metric | Nine months 2025 | Nine months 2024 | Interpretation |
|---|---|---|---|
| Net income | CNY 238.82 million | CNY 188.77 million | Year-over-year growth reflecting higher operating profitability |
| Basic EPS | CNY 0.43 | CNY 0.33 | EPS improvement consistent with net income gains |
| ROE | 11.29% | - | Indicates effective use of shareholders' equity |
| Net profit margin | 11.61% | - | Shows efficient cost management relative to revenue |
| Gross profit margin | 38.68% | - | Strong underlying product/service profitability |
| Trailing P/E | 28.86 | - | Moderate investor valuation relative to earnings |
- Margin profile: Gross margin of 38.68% supports a healthy net margin of 11.61%, implying operating and overhead costs are being controlled effectively.
- Return metrics: ROE at 11.29% combined with rising EPS signals improving capital efficiency and shareholder returns.
- Valuation context: A trailing P/E of 28.86 suggests the market prices in growth expectations-investors should compare this to peers and sector averages.
For broader context on ownership, trading behavior, and investor composition, see: Exploring Guang Zhou GRG Metrology & Test Co., Ltd. Investor Profile: Who's Buying and Why?
Guang Zhou GRG Metrology & Test Co., Ltd. (002967.SZ) - Debt vs. Equity Structure
Guang Zhou GRG Metrology & Test Co., Ltd. (002967.SZ) demonstrates a conservative-to-moderate capital structure, pairing manageable leverage with solid short-term liquidity and strong interest coverage. Key financial metrics give a clear picture of how the company balances debt and equity financing, funds working capital, and services its obligations.
- Debt-to-Equity Ratio: 0.49 - indicates a balanced approach to financing with equity predominating over debt.
- Current Ratio: 1.68 - suggests adequate short-term financial health and ability to meet near-term liabilities.
- Quick Ratio: 1.55 - shows sufficient immediate liquidity excluding inventories.
- Interest Coverage Ratio: 10.35 - reflects comfortable capacity to cover interest expense from operating earnings.
- Debt-to-EBITDA: 1.92 - signals moderate leverage; roughly two years of EBITDA would cover total debt.
- Enterprise Value: CNY 12.72 billion with EV/EBITDA of 14.14 - positions valuation in a reasonable range relative to earnings.
| Metric | Value | Interpretation |
|---|---|---|
| Debt-to-Equity Ratio | 0.49 | Low-to-moderate leverage; equity base is larger than debt. |
| Current Ratio | 1.68 | Adequate short-term liquidity. |
| Quick Ratio | 1.55 | Strong immediate liquidity excluding inventories. |
| Interest Coverage Ratio | 10.35 | High ability to service interest payments. |
| Debt-to-EBITDA | 1.92 | Moderate leverage; manageable repayment horizon vs. EBITDA. |
| Enterprise Value (EV) | CNY 12.72 billion | Market + net debt valuation snapshot. |
| EV/EBITDA | 14.14 | Valuation multiple indicating reasonable earnings pricing. |
Investors evaluating capital structure and risk exposure should weigh these figures alongside growth prospects, margin sustainability, and sector comparables. For deeper ownership and investor-behavior context, see Exploring Guang Zhou GRG Metrology & Test Co., Ltd. Investor Profile: Who's Buying and Why?
Guang Zhou GRG Metrology & Test Co., Ltd. (002967.SZ) - Liquidity and Solvency
Assessing Guang Zhou GRG Metrology & Test Co., Ltd. (002967.SZ)'s liquidity and solvency provides a clear view of its short-term resilience and long-term capital stability. The following metrics summarize its current financial positioning:
- Current Ratio: 1.68
- Quick Ratio: 1.55
- Interest Coverage Ratio: 10.35
- Debt-to-Equity Ratio: 0.49
- Debt-to-EBITDA: 1.92
- Return on Assets (ROA): 4.67%
| Metric | Value | Interpretation |
|---|---|---|
| Current Ratio | 1.68 | Comfortable coverage of short-term liabilities; above 1.5 is generally healthy |
| Quick Ratio | 1.55 | Strong immediate liquidity excluding inventories |
| Interest Coverage Ratio | 10.35 | Generous buffer to service interest expenses (EBIT/Interest) |
| Debt-to-Equity Ratio | 0.49 | Conservative capital structure; less than 0.5 implies limited reliance on debt |
| Debt-to-EBITDA | 1.92 | Manageable leverage; sub-3 is typically considered moderate |
| Return on Assets (ROA) | 4.67% | Efficient asset utilization delivering mid-single-digit returns |
Practical implications for investors:
- The current and quick ratios (1.68 and 1.55) indicate the company can meet short-term obligations without resorting to asset fire sales.
- An interest coverage ratio of 10.35 implies low near-term default risk on interest payments and flexibility to absorb rate shocks.
- The debt-to-equity ratio of 0.49 and debt-to-EBITDA of 1.92 point to conservative leverage and capacity for additional borrowing if needed for growth or M&A.
- ROA at 4.67% shows the company converts assets into profit reasonably well for its industry profile; monitoring trend direction is important.
For context on corporate direction and capital allocation priorities, see the company's strategic framing: Mission Statement, Vision, & Core Values (2026) of Guang Zhou GRG Metrology & Test Co., Ltd.
Guang Zhou GRG Metrology & Test Co., Ltd. (002967.SZ) - Valuation Analysis
Guang Zhou GRG Metrology & Test Co., Ltd. (002967.SZ) presents a mixed valuation profile: market-cap and multiples point to a moderate premium versus peers on book value and free-cash-flow metrics, while earnings multiples imply steady investor expectations.- Market capitalization: CNY 11.52 billion (P/S = 3.33) - implies moderate top-line valuation relative to sales.
- Trailing P/E: 28.86 - suggests investors pay a near-30x multiple for historical earnings.
- Forward P/E: 29.36 - indicates anticipated stable or modestly improving earnings trajectory priced in by the market.
- Enterprise value: CNY 12.72 billion with EV/EBITDA = 14.14 - reasonable operating-earnings valuation versus enterprise base.
- P/B ratio: 3.25 - priced at a significant premium to book value, signaling growth expectations or intangible asset value.
- EV/FCF: 35.44 - a relatively high valuation versus free cash flow, highlighting potential sensitivity to cash-flow performance.
| Metric | Value | Implication |
|---|---|---|
| Market Capitalization | CNY 11.52 billion | Company size and public market weight |
| P/S | 3.33 | Moderate valuation relative to revenues |
| Trailing P/E | 28.86 | Historical earnings multiple |
| Forward P/E | 29.36 | Market-implied near-term earnings growth |
| Enterprise Value | CNY 12.72 billion | Debt- and cash-adjusted valuation |
| EV/EBITDA | 14.14 | Operational earnings valuation |
| P/B | 3.25 | Premium to book value |
| EV/FCF | 35.44 | High valuation relative to free cash flow |
Guang Zhou GRG Metrology & Test Co., Ltd. (002967.SZ) - Risk Factors
- Concentration risk: ~92% of revenue is generated domestically, limiting diversification and exposing the company to China-specific macroeconomic, policy and regulatory shifts.
- Sector concentration: Over 70% of revenue derives from the manufacturing and transportation sectors, increasing sensitivity to sector-specific downturns and capex cycles.
- Asset aging and tech obsolescence: Approximately 40% of equipment is older than five years, which may reduce production efficiency, raise maintenance costs and slow adoption of new testing standards.
- Operational efficiency gap: Operating margin is 10%, materially below local peers at 15%-20%, implying either higher cost structure or lower pricing power.
- Leverage and interest-rate exposure: Debt-to-EBITDA stands at 1.92, indicating moderate leverage that could pressure cash flow under rising interest rates or earnings weakness.
- Innovation cadence risk: Difficulty keeping pace with rapid technological advancement-compounded by older equipment-could erode competitive position in high-precision metrology and testing services.
- Customer and contract concentration: Heavy reliance on a few large industrial customers in manufacturing/transport increases counterparty risk and negotiation pressure on pricing and terms.
| Metric | Value | Implication |
|---|---|---|
| Domestic revenue share | ~92% | Limited global diversification |
| Revenue from manufacturing & transportation | >70% | Sector concentration risk |
| Equipment >5 years old | ~40% | Potential productivity and obsolescence issues |
| Operating margin | 10% | Below local competitors (15%-20%) |
| Competitors' operating margin range | 15%-20% | Benchmark for margin improvement |
| Debt-to-EBITDA | 1.92x | Moderate leverage; interest-rate sensitivity |
- Cash flow and capex trade-offs: Management must balance reinvestment to replace aging equipment and tech upgrades against servicing debt and sustaining margins.
- Execution risk on international expansion: Moving beyond a 92% domestic base requires execution capability, regulatory navigation, and product/service adaptation.
- Margin recovery scenarios: To reach peer margins, the company would need cost optimization, pricing improvements, or higher-margin service mix-each with implementation risk.
Guang Zhou GRG Metrology & Test Co., Ltd. (002967.SZ) - Growth Opportunities
Guang Zhou GRG Metrology & Test Co., Ltd. is positioning to capture demand across multiple high-growth verticals by aligning product development, services expansion, and capital allocation to industry trends in precision measurement and testing.
- Strategic industry focus: special industries, automotive, integrated circuits, and data science - targeted development and sales efforts are concentrated here to leverage secular demand for higher-precision metrology.
- R&D intensity: in 2022 the company invested ~CNY 300 million in R&D, representing ~15% of annual revenue (implying 2022 revenue ≈ CNY 2,000 million), signaling a sustained innovation bias to support differentiated products.
- Service expansion: calibration and certification services were introduced in 2023 and are projected to add ~CNY 100 million in incremental revenue in the first year, diversifying income toward recurring service streams.
- Geographic diversification: explicit plans to expand global presence to reduce domestic market concentration and capture export and after-sales service opportunities in Europe, North America and Southeast Asia.
- Product roadmap: development of advanced metrology solutions to meet evolving industry standards (e.g., higher-precision coordinate measurement systems, semiconductor-specific metrology) presents addressable-market growth potential.
- Shareholder returns: commitment to distribute no less than 30% of the average annual distribution profit over any three consecutive fiscal years, indicating policy-aligned cash allocation to investors.
| Metric | 2022 Actual | 2023 Projection / Note |
|---|---|---|
| Revenue (CNY) | ≈ 2,000,000,000 | + CNY 100,000,000 potential from calibration & certification (first year) |
| R&D Spend (CNY) | 300,000,000 | Target: maintain high R&D ratio (~15%) to support product pipeline |
| R&D as % of Revenue | ≈ 15% | Strategic priority to sustain at or near this level |
| Projected First-Year Calibration Revenue | - | 100,000,000 |
| Shareholder Return Policy | - | Cumulative distribution ≥ 30% of average annual distribution profit over any 3 consecutive fiscal years |
| Target Markets | Automotive / IC / Special industries / Data science | Global expansion planned to reduce domestic dependency |
- Near-term revenue levers: cross-selling calibration/certification into existing customer base, ramping advanced metrology sales to semiconductor and automotive OEMs, and international channel development.
- Execution considerations: sustaining ~15% R&D while scaling services and overseas operations will require disciplined capital allocation and potential incremental SG&A for market entry.
- Investor-relevant metrics to track: R&D-to-revenue ratio, service revenue contribution (calibration & certification), export revenue share, gross margin by product vs service, and cumulative distribution adherence to the 30% policy.
Exploring Guang Zhou GRG Metrology & Test Co., Ltd. Investor Profile: Who's Buying and Why?
Guang Zhou GRG Metrology & Test Co., Ltd. (002967.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.